At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 77 enrolled
Drug / intervention
Placebo +3 moredrug
Likely dose
Amoxicillin Sandoz 500 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Surgical Treatment of Peri-implantitis With and Without Systemically Adjunctive Antibiotics A Prospective, Double Blind, Randomized, Three Armed, Parallel, Placebo Controlled Clinical Trial
In Brief
A Phase 4 clinical trial evaluating Placebo, Amoxicillin Sandoz, and 2 other interventions for Periodontal Diseases and Periimplantitis. Completed, enrolled 77 participants across 2 sites.
Detailed Summary
The purpose of this study is to investigate if the use of systemic adjunctive antibiotics in the treatment of periimplantitis is needed.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPeriodontal Diseases, Periimplantitis
CountriesSweden
Collaborators--
Timeline
Phase 4CompletedFinished
201520162017201820192020202120222023202420252026
First PostedJul 2014
Enrollment StartMar 2015
Primary CompletionMay 2022
TodayJul 2026
First PostedJul 9, 2014
Enrollment StartMar 1, 2015
Primary CompletionMay 27, 2022
TodayJul 2, 2026
Enrollment to primary: 7.2 yearsPosted 12.0 years ago
Interventions
Placebodrug
Place capsule to mimic antibiotics
Amoxicillin Sandozdrug
Tablet 500 mg amoxicillin Sandoz three times a day
Metronidazole Sanofidrug
400 mg metronidazole Sanofi administered three times a day (TID)
Phenoxymethylpenicillin Medadrug
1600 mg phenoxymethylpenicillin Meda, three time a day (TID)